ReviewThe American journal of case reports2023

Endometrial Adenocarcinoma with Discordant Microsatellite Stability Status Treated with First-Line Pembrolizumab: A Case Report and Narrative Review.

Christopher R Grant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.